Inogen Alliance, headquartered in the United States, is a leading global network of independent medical technology companies, specialising in the provision of innovative solutions for the healthcare industry. Founded in 2015, the alliance has rapidly expanded its operational reach across North America, Europe, and Asia, establishing itself as a key player in the medical device sector. The organisation focuses on enhancing patient care through its core services, which include regulatory consulting, quality management, and market access strategies. What sets Inogen Alliance apart is its collaborative approach, leveraging the expertise of its member companies to deliver tailored solutions that meet the unique needs of clients. With a commitment to excellence, Inogen Alliance has achieved notable recognition in the industry, positioning itself as a trusted partner for medical technology firms seeking to navigate complex regulatory landscapes.
How does Inogen Alliance's carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Mean score of companies in the Health Services industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Inogen Alliance's score of 27 is higher than 56% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Inogen Alliance's carbon emissions data for 2023 indicates a total of approximately 30,540 kg CO2e, all of which falls under Scope 3 emissions. This figure remains consistent with the 2022 emissions data, which also reported about 30,540 kg CO2e in Scope 3 emissions, with significant contributions from business travel (approximately 16,186.2 kg CO2e) and purchased goods and services (approximately 14,353.8 kg CO2e). Inogen Alliance is committed to reducing greenhouse gas emissions in alignment with broader industry standards. The European Commission has established a target to reduce emissions by at least 55% by 2030 compared to 1990 levels, which Inogen Alliance is expected to support through its initiatives. However, specific reduction targets from the Science Based Targets initiative (SBTi) have not been disclosed. The emissions data is not cascaded from any parent organisation, and all figures are reported directly from Inogen Alliance. The organisation's focus on Scope 3 emissions highlights its commitment to addressing indirect emissions associated with its value chain, which is a critical aspect of comprehensive climate action.
Access structured emissions data, company-specific emission factors, and source documents
| 2022 | 2023 | |
|---|---|---|
| Scope 1 | - | - | 
| Scope 2 | - | - | 
| Scope 3 | 30,540 | 00,000 | 
Climate goals typically focus on 2030 interim targets and 2050 net-zero commitments, aligned with global frameworks like the Paris Agreement and Science Based Targets initiative (SBTi) to ensure alignment with global climate goals.
Inogen Alliance has not publicly committed to specific 2030 or 2050 climate goals through the major frameworks we track. Companies often set interim 2030 targets and long-term 2050 net-zero goals to demonstrate measurable progress toward decarbonization.
